Cleared Traditional

K070630 - HEALTH LINE INTERNATIONAL CORPORATION'S...

K070630 is an FDA 510(k) clearance for HEALTH LINE INTERNATIONAL CORPORATION'S..., manufactured by Health Line International Corporation (Hlic). The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 177-day FDA review.

K070630 · Health Line International Corporation (Hlic) · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2007
Decision
177d
Days
Class 2
Risk

K070630 is an FDA 510(k) clearance for the HEALTH LINE INTERNATIONAL CORPORATION'S PRIMARY IV SOLUTION ADMINISTRATION SE.... Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Health Line International Corporation (Hlic) (Clearfield, US). The FDA issued a Cleared decision on August 31, 2007 after a review of 177 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Health Line International Corporation (Hlic) devices

FDA 510(k) Submission Details - K070630

510(k) Number K070630 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 07, 2007
Decision Date August 31, 2007
Days to Decision 177 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
48d slower than avg
Panel avg: 129d · This submission: 177d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 535
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K070630.
SMARTPORT CT MP PORT ACCESS SYSTEM AND LIFEGUARD CT SAFETY INFUSION SET
K072375 · AngioDynamics, Inc. · Dec 2007
CLEARLINK ANTIMICROBIAL LUER ACTIVATED DEVICE (LAD) AND EXTENSION SETS WITH THE CLEARLINK ANTIMICROBIAL LUER ACTIVATED
K072576 · Baxter Healthcare Corp · Nov 2007
SURFLO WINGED INFUSION SET WITH NEEDLE PROTECTION (SURSHIELD)
K072894 · Terumo Europe N.V. · Nov 2007
SURFLO WINGED INFUSION SET WITH FILTER AND NEEDLE PROTECTION (SURSHIELD)
K070547 · Terumo Europe N.V. · May 2007
SURFLO WINGED INFUSION SET
K070362 · Terumo Europe N.V. · May 2007
SPIROS
K070532 · Icu Medical, Inc. · Mar 2007